Fang Xiang
Direttore/Membro del Consiglio presso Hrain Biotechnology Co., Ltd.
Profilo
Fang Xiang is currently a Member-Supervisory Board & Medical Director at Hrain Biotechnology Co., Ltd.
His education includes a graduate degree from Wuhan University in 2004.
Posizioni attive di Fang Xiang
| Società | Posizione | Inizio |
|---|---|---|
Hrain Biotechnology Co., Ltd.
 Hrain Biotechnology Co., Ltd. BiotechnologyHealth Technology Hrain Biotechnology Co., Ltd. engages in the research and development, and production of immune cell therapy products. It offers chimeric antigen receptor (CAR) T-cell therapy, chimeric antigen receptor-transduced natural killer (CAR-NK) cell therapy, dash chimeric antigen receptor (CAR) T-cell therapy. The company was founded by Pin Wang on July 20, 2015 and is headquartered in Shanghai, China. | Direttore/Membro del Consiglio | 18/06/2021 |
Formazione di Fang Xiang
| Wuhan University | Graduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
Hrain Biotechnology Co., Ltd.
Hrain Biotechnology Co., Ltd. BiotechnologyHealth Technology Hrain Biotechnology Co., Ltd. engages in the research and development, and production of immune cell therapy products. It offers chimeric antigen receptor (CAR) T-cell therapy, chimeric antigen receptor-transduced natural killer (CAR-NK) cell therapy, dash chimeric antigen receptor (CAR) T-cell therapy. The company was founded by Pin Wang on July 20, 2015 and is headquartered in Shanghai, China. | Health Technology |
- Borsa valori
- Insiders
- Fang Xiang